Keyphrases
Patient Survival
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Cell-free DNA (cfDNA)
100%
Computed Tomography
42%
Non-small Cell Lung Cancer Patients
42%
Confidence Interval
28%
Progression-free Survival
28%
Overall Survival
28%
Hazard Ratio
28%
Multivariate Analysis
14%
Chemotherapy
14%
Prognostic Factors
14%
Percent Change
14%
Best Response
14%
Prognostic Value
14%
Adenocarcinoma
14%
Concentration Change
14%
Tumor Response
14%
Patient Prognosis
14%
Blood Collection
14%
Predictive Efficacy
14%
Cox Regression
14%
Naïve Patients
14%
X-tile
14%
Chemo-naive
14%
Prospective Biomarkers
14%
DNA Quantification
14%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Cell-Free DNA
100%
Computer Assisted Tomography
75%
Hazard Ratio
50%
Overall Survival
50%
Progression Free Survival
50%
Biological Marker
25%
Multivariate Analysis
25%
Neoplasm
25%
Adenocarcinoma
25%
Prognostic Factor
25%
Proportional Hazards Model
25%
Blood Sampling
25%
Chemotherapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Progression Free Survival
50%
Overall Survival
50%
Neoplasm
25%
Biological Marker
25%
Chemotherapy
25%
Adenocarcinoma
25%
Biochemistry, Genetics and Molecular Biology
Computer Assisted Tomography
100%
Overall Survival
66%
Progression Free Survival
66%
Multivariate Analysis
33%
Blood Sampling
33%
Agricultural and Biological Sciences
Lung
100%
Computed Tomography
75%
Confidence Interval
50%
Multivariate Analysis
25%
Blood Sampling
25%